TABLE 3.

NPH and lispro insulin doses throughout visits 1–8 of dogs treated with lispro and neutral protamine Hagedorn insulins

Visit	NPH insulin dose Median (range)*	Lispro insulin dose Median (range)*
0**	0.445 (0.3–1.04)	‐
1	0.445 (0.3–1.04)	0.07 (0.06–0.19)
2	0.48 (0.27–0.85)	0.08 (0.06–0.19)
3	0.555 (0.26–0.82)	0.08 (0.06–0.14)
4	0.49 (0.29–0.96)	0.08 (0.07–0.13)
5	0.53 (0.29–1.17)	0.08 (0.07–0.13)
6	0.49 (0.29–1.25)	0.08 (0.06–0.125)
7	0.47 (0.3–0.95)	0.08 (0.06–0.09)
8	0.495 (0.29–0.95)	0.08 (0.06–0.09)

^*Units/kg, doses refer to the prescribed treatment during the 2–4 weeks prior to the evaluation visit.

**Visit 0 was the visit in which basal‐bolus insulin treatment protocol was initiated. Visit 1 was the first recorded visit following 2 weeks of combined NPH and lispro insulin treatment. All dogs received insulin treatment every 12 h, prior and following inclusion. One dog was treated with glargine insulin (0.75 unit/kg every 12 h) prior to inclusion.